Active targeting of dendritic cells with mannan-decorated PLGA nanoparticles

The purpose of this study was to identify an optimum targeted particulate formulation based on mannan (MN)-decorated poly(D, L-lactide-co-glycolide) (PLGA) nanoparticles (NPs), for efficient delivery of incorporated cargo to dendritic cells (DCs). In brief, NPs were formulated from two different types of PLGA; ester-terminated (capped) or COOH-terminated (uncapped) polymer. Incorporation of MN in NPs was achieved either through addition of MN during the process of NP formation or by attachment of MN onto the surface of the freeze dried NPs by physical adsorption or chemical conjugation (to COOH terminated polymer). The formulated NPs were characterized in terms of particle size, Zeta potential and level of MN incorporation. The effect of polymer type and the incorporation method on the extent of fluorescently labelled NP uptake by murine bone marrow-derived DCs have been investigated using flowcytometry. The results of this study showed MN incorporation to enhance the uptake of PLGA NPs by DCs. Among different MN incorporation strategies, covalent attachment of MN to COOH-terminated PLGA-NPs provided the highest level of MN surface decoration on NPs. Maximum NP uptake by DCs was achieved by COOH terminated PLGA NPs containing covalent or adsorbed MN. Therefore, a better chance of success for these formulations for active targeted drug and/or vaccine delivery to DCs is anticipated.

[1]  T. Keler,et al.  Mannose receptor-targeted vaccines , 2004, Expert opinion on biological therapy.

[2]  T. Gajewski,et al.  Cancer immunotherapy , 2012, Molecular oncology.

[3]  Marcus Groettrup,et al.  Concomitant delivery of a CTL-restricted peptide antigen and CpG ODN by PLGA microparticles induces cellular immune response , 2009, Journal of drug targeting.

[4]  C. Cho,et al.  The potential of mannosylated chitosan microspheres to target macrophage mannose receptors in an adjuvant-delivery system for intranasal immunization. , 2008, Biomaterials.

[5]  M. Becker,et al.  Synthesis, characterization, and bioavailability of mannosylated shell cross-linked nanoparticles. , 2004, Biomacromolecules.

[6]  Sven Frokjaer,et al.  Particle size and surface charge affect particle uptake by human dendritic cells in an in vitro model. , 2005, International journal of pharmaceutics.

[7]  A. Alshamsan,et al.  Enhanced antigen-specific primary CD4+ and CD8+ responses by codelivery of ovalbumin and toll-like receptor ligand monophosphoryl lipid A in poly(D,L-lactic-co-glycolic acid) nanoparticles. , 2007, Journal of biomedical materials research. Part A.

[8]  V. Apostolopoulos,et al.  Pilot phase III immunotherapy study in early-stage breast cancer patients using oxidized mannan-MUC1 [ISRCTN71711835] , 2006, Breast Cancer Research.

[9]  P. Stahl,et al.  The mannose receptor is a pattern recognition receptor involved in host defense. , 1998, Current opinion in immunology.

[10]  V. Apostolopoulos,et al.  Ex vivo targeting of the macrophage mannose receptor generates anti-tumor CTL responses. , 2000, Vaccine.

[11]  A. Schaper,et al.  Influence of morphology and drug distribution on the release process of FITC-dextran-loaded microspheres prepared with different types of PLGA , 2009, Journal of microencapsulation.

[12]  Praveen Elamanchili,et al.  Characterization of poly(D,L-lactic-co-glycolic acid) based nanoparticulate system for enhanced delivery of antigens to dendritic cells. , 2004, Vaccine.

[13]  J. Gready,et al.  The C‐type lectin‐like domain superfamily , 2005, The FEBS journal.

[14]  Sanyog Jain,et al.  Mannosylated Niosomes as Adjuvant-Carrier System for Oral Mucosal Immunization , 2006, Journal of liposome research.

[15]  A. Alshamsan,et al.  Co-delivery of cancer-associated antigen and Toll-like receptor 4 ligand in PLGA nanoparticles induces potent CD8+ T cell-mediated anti-tumor immunity. , 2008, Vaccine.

[16]  J. Drijfhout,et al.  Soluble mannosylated myelin peptide inhibits the encephalitogenicity of autoreactive T cells during experimental autoimmune encephalomyelitis. , 2007, The American journal of pathology.

[17]  C. Specht,et al.  A Model Vaccine Exploiting Fungal Mannosylation to Increase Antigen Immunogenicity1 , 2005, The Journal of Immunology.

[18]  M. Wright,et al.  Mannan derivatives induce phenotypic and functional maturation of mouse dendritic cells , 2006, Immunology.

[19]  S. Della Bella,et al.  Keyhole limpet hemocyanin induces the activation and maturation of human dendritic cells through the involvement of mannose receptor. , 2008, Molecular immunology.

[20]  Hao Wang,et al.  Targeted Delivery of Tumor Antigens to Activated Dendritic Cells via CD11c Molecules Induces Potent Antitumor Immunity in Mice , 2009, Clinical Cancer Research.

[21]  J. Vörös,et al.  Improved Stimulation of Human Dendritic Cells by Receptor Engagement with Surface-modified Microparticles , 2003, Journal of drug targeting.

[22]  M. Ueda,et al.  Optimization of the preparation of loperamide-loaded poly (L-lactide) nanoparticles by high pressure emulsification-solvent evaporation. , 1997, Journal of microencapsulation.

[23]  S. Rosenberg,et al.  Cancer immunotherapy: moving beyond current vaccines , 2004, Nature Medicine.

[24]  D. Busch,et al.  TLR ligands and antigen need to be coencapsulated into the same biodegradable microsphere for the generation of potent cytotoxic T lymphocyte responses. , 2008, Vaccine.

[25]  M. Textor,et al.  Mannose-based molecular patterns on stealth microspheres for receptor-specific targeting of human antigen-presenting cells. , 2008, Langmuir : the ACS journal of surfaces and colloids.

[26]  R. Furneaux,et al.  Mannosylated liposomes as antigen delivery vehicles for targeting to dendritic cells , 2006, The Journal of pharmacy and pharmacology.

[27]  B. Frisch,et al.  Influence of ligand valency on the targeting of immature human dendritic cells by mannosylated liposomes. , 2008, Bioconjugate chemistry.

[28]  Vasso Apostolopoulos,et al.  Pathogen recognition and development of particulate vaccines: does size matter? , 2006, Methods.

[29]  G. Schuler,et al.  An advanced culture method for generating large quantities of highly pure dendritic cells from mouse bone marrow. , 1999, Journal of immunological methods.

[30]  K. Sheng,et al.  Delivery of antigen using a novel mannosylated dendrimer potentiates immunogenicity in vitro and in vivo , 2008, European journal of immunology.

[31]  E. Vinogradov,et al.  Structural analysis of the intact polysaccharide mannan from Saccharomyces cerevisiae yeast using 1H and 13C NMR spectroscopy at 750 MHz. , 1998, Carbohydrate research.

[32]  Praveen Elamanchili,et al.  Biodegradable Nanoparticle Mediated Antigen Delivery to Human Cord Blood Derived Dendritic Cells for Induction of Primary T Cell Responses , 2003, Journal of drug targeting.

[33]  Richard J. Stillion,et al.  Mannose Receptor Expression and Function Define a New Population of Murine Dendritic Cells1 , 2007, The Journal of Immunology.

[34]  M. Ozkan,et al.  Delivery of a peptide via poly(D,L-lactic-co-glycolic) acid nanoparticles enhances its dendritic cell-stimulatory capacity. , 2010, Nanomedicine : nanotechnology, biology, and medicine.

[35]  John Samuel,et al.  Biodegradable nanoparticle delivery of a Th2‐biased peptide for induction of Th1 immune responses , 2006, The Journal of pharmacy and pharmacology.

[36]  J. Shapiro,et al.  Delivery of rapamycin by PLGA nanoparticles enhances its suppressive activity on dendritic cells. , 2008, Journal of biomedical materials research. Part A.

[37]  Y. van Kooyk.  C-type lectins on dendritic cells: key modulators for the induction of immune responses. , 2008, Biochemical Society transactions.

[38]  S. Hamdy,et al.  “Pathogen-Mimicking” Nanoparticles for Vaccine Delivery to Dendritic Cells , 2007, Journal of immunotherapy.

[39]  Ana Jaklenec,et al.  Sequential release of bioactive IGF-I and TGF-beta 1 from PLGA microsphere-based scaffolds. , 2008, Biomaterials.

[40]  Alessandra Cambi,et al.  Dendritic Cell Interaction with Candida albicans Critically Depends on N-Linked Mannan* , 2008, Journal of Biological Chemistry.

[41]  S. Nishimura,et al.  Carbohydrate analysis by a phenol-sulfuric acid method in microplate format. , 2005, Analytical biochemistry.

[42]  S. Siegel,et al.  Production of haloperidol-loaded PLGA nanoparticles for extended controlled drug release of haloperidol , 2005, Journal of microencapsulation.

[43]  P. Bailly,et al.  Molecular characterization of the human macrophage mannose receptor: demonstration of multiple carbohydrate recognition-like domains and phagocytosis of yeasts in Cos-1 cells , 1990, The Journal of experimental medicine.

[44]  A. Lanzavecchia,et al.  The mannose receptor functions as a high capacity and broad specificity antigen receptor in human dendritic cells , 1997, European journal of immunology.